Loading...
Alpha Teknova, Inc.
TKNO•NASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$5.18
$0.010(0.19%)
Alpha Teknova, Inc. (TKNO) Financial Performance & Income Statement Overview
Review Alpha Teknova, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
2.89%
↑ 2.89%
Operating Income Growth
26.48%
↑ 26.48%
Net Income Growth
27.28%
↑ 27.28%
Operating Cash Flow Growth
34.007%
↑ 34.007%
Operating Margin
-60.45%
↓ 60.45%
Gross Margin
20.99%
↑ 20.99%
Net Profit Margin
-60.90%
↓ 60.90%
ROE
-28.48%
↓ 28.48%
ROIC
-21.62%
↓ 21.62%
Alpha Teknova, Inc. (TKNO) Income Statement & Financial Overview
Review Alpha Teknova, Inc.'s (TKNO) income statement with detailed quarterly and annual figures.
| Metric | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|
| Revenue | $9.58M | $9.61M | $9.29M | $7.87M |
| Cost of Revenue | $9.49M | $6.81M | $7.37M | $6.82M |
| Gross Profit | $90000.00 | $2.80M | $1.92M | $1.05M |
| Gross Profit Ratio | $0.009 | $0.29 | $0.21 | $0.13 |
| R&D Expenses | $627000.00 | $678000.00 | $860000.00 | $1.31M |
| SG&A Expenses | $6.61M | $6.94M | $7.75M | $8.43M |
| Operating Expenses | $7.52M | $7.62M | $8.61M | $9.74M |
| Total Costs & Expenses | $17.008M | $14.43M | $15.98M | $16.56M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $141000.00 | $272000.00 | $145000.00 | $440000.00 |
| Depreciation & Amortization | $0.00 | $1.63M | $1.64M | $1.61M |
| EBITDA | -$7.43M | -$3.47M | -$6.35M | -$8.18M |
| EBITDA Ratio | -$0.78 | -$0.53 | -$0.54 | -$0.90 |
| Operating Income | -$7.43M | -$5.10M | -$6.69M | -$8.69M |
| Operating Income Ratio | -$0.78 | -$0.53 | -$0.72 | -$1.10 |
| Other Income/Expenses (Net) | -$141000.00 | -$272000.00 | -$145000.00 | -$102000.00 |
| Income Before Tax | -$7.57M | -$5.37M | -$8.13M | -$10.96M |
| Income Before Tax Ratio | -$0.79 | -$0.56 | -$0.88 | -$1.39 |
| Income Tax Expense | -$8000.00 | -$8000.00 | -$34000.00 | -$304000.00 |
| Net Income | -$7.57M | -$5.36M | -$8.10M | -$10.66M |
| Net Income Ratio | -$0.79 | -$0.56 | -$0.87 | -$1.35 |
| EPS | -$0.17 | -$0.13 | -$0.20 | -$0.26 |
| Diluted EPS | -$0.17 | -$0.13 | -$0.20 | -$0.26 |
| Weighted Avg Shares Outstanding | $44.52M | $40.85M | $40.80M | $40.75M |
| Weighted Avg Shares Outstanding (Diluted) | $44.52M | $40.85M | $40.80M | $40.75M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan